Vanberra Signal

Nemo Healthcare

Curated by Signal

Developer of fetal monitoring technology

Overview

Nemo Healthcare is a developer of electrophysiological monitoring sensors for the feto-maternal devices. The device PUREtrace directly monitors the uterine activity, tracking the electrical muscle activity of the uterus for fetal monitoring. The devices have multi surface-electrode Graphium electrode patch, which is compatible with fetal monitors such as Philips 50-series, Philips Avalon FM30 en FM50, Neoventa Stan S21 / S31, and GE Healthcare Corometrics 250 series. The device has been FDA 510(k) cleared (K153262), non-invasively measuring the intrapartum uterine activity. The device received market clearance in Feb 2017.

Key facts

Founded
2009

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of cannabis-based nutritional and wellness products

    Life Sciences TechnologyBreda, Netherlands
  • Developer of medical devices for the treatment of infertility

    Life Sciences TechnologyAmsterdam, Netherlands
  • Developer of liquid biopsybased diagnostic test for cancer detection

    Life Sciences TechnologyUtrecht, Netherlands

About Nemo Healthcare

What does Nemo Healthcare do?

Nemo Healthcare is a developer of electrophysiological monitoring sensors for the feto-maternal devices.

Where is Nemo Healthcare headquartered?

Nemo Healthcare is headquartered in Veldhoven, Netherlands.

When was Nemo Healthcare founded?

Nemo Healthcare was founded in 2009.

Which sector is Nemo Healthcare in?

Nemo Healthcare operates in Life Sciences Technology.

Who are Nemo Healthcare's competitors?

Companies similar to Nemo Healthcare include The Noori, FERTI·LILY, and Cyclomics.